chr1-228158286-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BS1BS2
The NM_020435.4(GJC2):c.528G>A(p.Glu176=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000679 in 1,533,678 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00094 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00065 ( 8 hom. )
Consequence
GJC2
NM_020435.4 synonymous
NM_020435.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.948
Genes affected
GJC2 (HGNC:17494): (gap junction protein gamma 2) This gene encodes a gap junction protein. Gap junction proteins are members of a large family of homologous connexins and comprise 4 transmembrane, 2 extracellular, and 3 cytoplasmic domains. This gene plays a key role in central myelination and is involved in peripheral myelination in humans. Defects in this gene are the cause of autosomal recessive Pelizaeus-Merzbacher-like disease-1. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 1-228158286-G-A is Benign according to our data. Variant chr1-228158286-G-A is described in ClinVar as [Benign]. Clinvar id is 458297.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr1-228158286-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.948 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00094 (143/152124) while in subpopulation EAS AF= 0.0151 (78/5160). AF 95% confidence interval is 0.0124. There are 2 homozygotes in gnomad4. There are 88 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GJC2 | NM_020435.4 | c.528G>A | p.Glu176= | synonymous_variant | 2/2 | ENST00000366714.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GJC2 | ENST00000366714.3 | c.528G>A | p.Glu176= | synonymous_variant | 2/2 | 1 | NM_020435.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000921 AC: 140AN: 152008Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
140
AN:
152008
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00172 AC: 236AN: 137028Hom.: 2 AF XY: 0.00178 AC XY: 133AN XY: 74748
GnomAD3 exomes
AF:
AC:
236
AN:
137028
Hom.:
AF XY:
AC XY:
133
AN XY:
74748
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000650 AC: 898AN: 1381554Hom.: 8 Cov.: 36 AF XY: 0.000686 AC XY: 467AN XY: 680844
GnomAD4 exome
AF:
AC:
898
AN:
1381554
Hom.:
Cov.:
36
AF XY:
AC XY:
467
AN XY:
680844
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000940 AC: 143AN: 152124Hom.: 2 Cov.: 32 AF XY: 0.00118 AC XY: 88AN XY: 74376
GnomAD4 genome
AF:
AC:
143
AN:
152124
Hom.:
Cov.:
32
AF XY:
AC XY:
88
AN XY:
74376
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
36
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 11, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at